Come up with a name for your new list and we'll add to it:
BioMarker Strategies raised a round of funding on November 22, 2010. Investors include
Qualifying Therapeutic Discovery Project.
BioMarker Strategies is a tissue-based cancer diagnostics company that is developing the SnapPath live tumor cell testing platform to improve the treatment of cancer. This ex vivo biomarker platform w…